Natco Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 2,314.75 1.80  | 0.08% 114.60% 57.34 7,718.63
NSE Price: Aug 03, 15:56 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Aug 03, 15:56 2,314.75 1.80 0.08% 2,319.80 2,312.95 31,410 2,301.00 - 2,356.80
BSE Aug 03, 15:54 2,322.60 16.75 0.73% 2,324.90 2,305.85 2,902 2,306.10 - 2,354.10
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 157,796 P/B: 9.12 NSE Code: NATCOPHARM
52-Week Range: R 1,000.50 - 2,709.85 Dividend Yield: 0.22% BSE Code: 524816
TTM EPS: R 40.50 Book Value: R 254.57 Face Value: R 10
Price Graph
  • Divi's Laboratories (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Natco Pharma 51.15 1.29 8.19 114.34 88.12 63.85 34.29
S&P BSE Mid Cap 11.24 5.55 8.22 31.63 25.71 11.48 -
S&P BSE Healthcare 16.28 2.92 5.32 38.46 33.56 23.82 -
Company's return has been calculated on basis of NSE's price.
As on Jul 31, 2015
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 11.86 17.14 10.75
Net Profit 48.91 23.64 16.69
EPS 35.60 17.78 14.65
Book Value 29.06 20.57 19.03
Average
Operating Margin 26.53 24.58 23.09
Net Margin 12.98 11.25 11.06
Return on Networth 15.58 14.27 15.12
Return on Investment 18.02 16.60 16.90
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.73 9.25 9.25
Operating Profit -4.08 11.52 11.52
Net Profit 289.09 108.51 108.51
EPS 279.64 125.55 125.55
TTM
Revenue 2.10 11.71 11.71
Operating Profit 2.44 16.44 16.44
Net Profit 26.96 32.96 32.96
EPS 28.96 459.03 459.03
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Natco Pharma 7,718.63 825.45 130.26 15.49 15.58 9.12 57.34
Divi's Laboratories 26,341.12 3,084.01 847.06 26.84 28.31 7.54 30.93
Torrent Pharmaceuticals 24,248.77 5,486.00 944.00 16.30 34.19 8.25 25.69
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Apr 06, 2015 B R Reddy  Sell ESOP 2,000 2,428.15 48.56
Apr 06, 2015 M Srikanth  Sell ESOP 1,000 2,428.15 24.28
Jan 24, 2015 NDL Infratech Pvt Ltd  Buy Preferential Allotment 18,750 1,362.25 255.42
Jan 24, 2015 Rajeev Nanrapaneni  Buy Preferential Allotment 625 1,362.25 8.51
Jan 24, 2015 Timecap Prama Labs Ltd  Buy Preferential Allotment 18,750 1,362.25 255.42
Fund Houses invested in the stock
Fund Jun-15 Mar-15 Dec-14 Sep-14 Jun-14
ICICI Prudential Mutual Fund 2.531 2.592 3.326 3.443 -
SBI Mutual Fund 1.208 1.129 1.978 0.759 2.120
Mirae Asset Mutual Fund 0.494 0.451 0.424 0.388 0.115
UTI Mutual Fund 0.380 0.407 0.392 0.372 0.393
L&T Mutual Fund 0.218 0.416 0.575 0.759 0.854
Pramerica Mutual Fund 0.033 - - - -
Shriram Mutual Fund 0.003 0.003 0.003 0.004 0.002
Goldman Sachs Mutual Fund 0.001 - - - -
Sahara Mutual Fund NA 0.003 0.005 0.006 -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Natco Pharma Ltd.

Address: Natco House, Road No 2, Banjara Hills, Hyderabad, Andhra Pradesh - 500033 | Phone: +91-40- 23547532 | Fax: +91-40- 23548243

Email: investors@natcophrma.co.in

Website: www.natcopharma.co.in

Registrar & Transfer Agent: Venture Capital & Corporate Investments Ltd

Address: 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad | Phone: 91-40-23818475/6 | Fax: 91-40-23868024

Email: info@vccilindia.com

comments powered by Disqus
Related Stocks
Ajanta Pharma ₹1,551.50 -0.79%
Alembic Pharmaceuticals ₹736.65 -1.17%
Biocon ₹462.20 +1.37%
Divi's Laboratories ₹1,972.50 +2.19%
Pfizer ₹2,292.90 +5.38%
Piramal Enterprises ₹901.05 -2.08%
Sun Pharma Adv. Research ₹401.15 -1.16%
Torrent Pharmaceuticals ₹1,426.40 -1.06%
Wockhardt ₹1,585.75 +6.68%
Sun Pharmaceutical Inds. ₹830.95 +2.05%
As on Aug 03, 15:59